UPC_CFI_202/2025

A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER

Provisional measuresProvisional MeasuresMilan LDProvisional measuresCase ClosedSettled at: Pre-PI

Overview Decisions Reasoning Citations Documents Timeline

Coverage: Partial.Reasoning extracted with partial coverage — some sections may be incomplete.

Plain-English summary

Edwards Lifesciences Corporation's application for provisional measures against Sintec s.r.l. and Value Med s.r.l. concerning EP 3 646 825 (prosthetic valve delivery system) settled following judge-rapporteur-facilitated negotiations at the Milan Local Division. The Court confirmed the settlement as an enforceable final decision under Art. 79 UPCA and R. 365 RoP, but dismissed Edwards' request for 60% reimbursement of court fees.

Accepted arguments

What the court agreed with — by party.

Settlement agreement between Edwards Lifesciences and Sintec/Value Med to be confirmed as enforceable decision under Art. 79 UPCA and R. 365.1 RoP
ClaimantLegal basis: Art. 79 UPCA; R. 365.1 RoP
Note: Court confirmed the settlement signed 23 June 2025 and made it enforceable as a final court decision.
Redacted version of settlement to be published, with full text confidential
ClaimantLegal basis: R. 365 RoP
Note: Court ordered publication of redacted version only.

Rejected arguments

What the court did not agree with — and why.

60% reimbursement of court fees (EUR 6,600) requested by Edwards under R. 370.9(c) and 370.11 RoP
ClaimantLegal basis: R. 370.9(c) RoP; R. 370.11 RoP
Reason: Request for court fee reimbursement was dismissed; specific grounds not reproduced in the available excerpt.

Key legal principles

Doctrines and rules cited in the reasoning.

confirmation of settlement as enforceable final decision under Art. 79 UPCA court-facilitated settlement under case management powers (R. 332 RoP)publication of redacted settlement only under R. 365 RoP court fee reimbursement on settlement not automatic

Browse other cases on this principle.